Peritransplant eculizumab does not prevent delayed graft function in deceased donor kidney transplant recipients: Results of two randomized controlled pilot trials

Peritransplant eculizumab does not prevent delayed graft function in deceased donor kidney transplant recipients: Results of two randomized controlled pilot trials

Animal models and observational human data indicate that complement, including C5a, pathogenically participates in ischemia reperfusion (IR) injury that manifests as delayed graft function (DGF) following deceased donor kidney transplantation. We report on the safety/efficacy of anti-C5 monoclonal a...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Bernd Schröppel, Enver Akalin, Mukta Baweja, Roy D. Bloom, Sander Florman, Michael J. Goldstein, Brandy Haydel, Donald E. Hricik, Sanjay Kulkarni, Matthew H. Levine, Anita Mehrotra, Anup Patel, Emilio D. Poggio, Lloyd E. Ratner, Ron Shapiro, Peter S. Heeger
Materialtyp: Artigo
Språk:engelska
Publicerad: 2019
Länkar:https://doi.org/10.1111/ajt.15580
https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ajt.15580
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Internet

https://doi.org/10.1111/ajt.15580
https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ajt.15580

Liknande verk